Safety assessment of the commensal strain Bacteroides xylanisolvens DSM 23964.

Ulsemer P, Toutounian K, Schmidt J, Leuschner J, Karsten U, Goletz S. Regul Toxicol Pharmacol. 2012 Mar;62(2):336-46. doi: 10.1016/j.yrtph.2011.10.014.

Read more
Determination of MUC1 in sera of ovarian cancer patients and in sera of patients with benign changes of the ovaries with CA15-3, CA27.29, and PankoMab

Jeschke U, Wiest I, Schumacher AL, Kupka M, Rack B, Stahn R, Karsten U, Mayr D, Friese K, Dian D. Anticancer Res. 2012 May;32(5):2185-9.

Read more
Safety and tolerance of Bacteroides xylanisolvens DSM 23964 in healthy adults.

Ulsemer P, Toutounian K, Kressel G, Schmidt J, Karsten U, Hahn A, Goletz S. Benef Microbes. 2012 Jun 1;3(2):99-111. doi: 10.3920/BM2011.0051.

Read more
Preliminary safety evaluation of a new Bacteroides xylanisolvens isolate.

Ulsemer P, Toutounian K, Schmidt J, Karsten U, Goletz S. Appl Environ Microbiol. 2012 Jan;78(2):528-35. doi: 10.1128/AEM.06641-11.

Read more